openPR Logo
Press release

Rising Cancer Prevalence Fuels Surge In Demand For Targeted Therapy: A Key Driver Powering Targeted Therapy Market Growth In 2025

05-15-2025 07:07 AM CET | Health & Medicine

Press release from: The Business Research Company

Targeted Therapy

Targeted Therapy

The Targeted Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Targeted Therapy Market?
In the past few years, the market size for targeted therapy has experienced robust growth. The market is projected to rise from $103.84 billion in 2024 to $111.47 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.3%. This growth during the historical period is linked to progress in molecular biology, the rise in cancer cases, the trend towards personalized medicine, approvals from the FDA, and regulatory support.

The market size for targeted therapy is expected to experience robust growth in the coming years, increasing to $151.48 billion in 2029 with a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this predicted increase in the forecast period range from advances in oncology research and a surge in demand for precision medicine, to the emergence of immunotherapies and increased investments in biopharmaceuticals, alongside patient awareness and advocacy. Key trends forecasted to influence this growth period include the incorporation of artificial intelligence (AI) into drug discovery, patient advocacy and involvement in treatment decisions, the growth of companion diagnostics, regulatory backing for rapid approvals, and a rise in investment in the sectors of biotechnology and pharmaceuticals.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9129

What Are the Different Targeted Therapy Market Segments?
The targeted therapy market covered in this report is segmented -

1) By Type: Small Molecule Medicines, Monoclonal Antibodies
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

Subsegments:
1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies
2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

What Are the Primary Drivers Shaping the Targeted Therapy Market?
The escalation in cancer cases is anticipated to fuel the expansion of the targeted therapy market in future. Cancer, a term for conditions characterized by abnormal cells that infect surrounding tissues and multiply uncontrollably, can be mitigated through targeted therapy. This approach blocks the signals promoting cancer cell growth or triggers these cells to self-destroy. By specifically addressing genes and proteins that support cancer cell growth and persistence, targeted therapy has seen increased demand. For example, data from American Cancer Society, a US-based nonprofit advocating for cancer, showed that the number of cancer cases rose to 2,001,140 in January 2024 from 1,958,310 in 2023, translating to a growth of 2.19%. Hence, the burgeoning prevalence of cancer is set to stimulate the growth of the targeted therapy market.

Which Companies Are Leading in the Targeted Therapy Market?
Major companies operating in the targeted therapy market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

What Are the Major Trends Shaping the Targeted Therapy Market?
Prominent corporations in the targeted therapy marketplace are concentrating on creating innovative tech solutions to bolster their market stance. For example, in March 2022, Novartis AG, a multinational pharmaceutical firm from Switzerland, presented Pluvicto, endorsed by the US Food and Drug Administration (FDA). This represents the first FDA-approved targeted radioligand therapy (RLT) suitable for patients with mCRPC. Pluvicto fuses a therapeutic radioisotope with a specifically selected chemical (a radioactive particle), representing a targeted cancer treatment kind where a therapeutic radioisotope merges with a particular chemical. Pluvicto has the ability to adhere to circulatory target cells, including those expressing the PSMA transmembrane protein, such as prostate cancer cells. When bound, the radioisotope's energy emissions harm the targeted cells and nearby cells, hindering their replication process and, in certain cases, causing cellular death.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

What Are the Top Revenue-Generating Geographies in the Targeted Therapy Market?
North America was the largest region in the targeted therapy market in 2024. The regions covered in the targeted therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Targeted Therapy Market?
2. What is the CAGR expected in the Targeted Therapy Market?
3. What Are the Key Innovations Transforming the Targeted Therapy Industry?
4. Which Region Is Leading the Targeted Therapy Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Cancer Prevalence Fuels Surge In Demand For Targeted Therapy: A Key Driver Powering Targeted Therapy Market Growth In 2025 here

News-ID: 4016904 • Views:

More Releases from The Business Research Company

Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: Powering Innovation and Expansion in the Diamond Market by 2025
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Diamond Market Through 2025? In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025? In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.18 Billion Milestone
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Professional Street Sweeper Market Size By 2025? The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtration Technologies Empower Compliance With Environmental Standards Industry Transformation
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a

All 5 Releases


More Releases for Targeted

Targeted Alpha Therapy Market
Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights: • Global Targeted Alpha Therapy Market Insight By Region • Approved Targeted Alpha Therapy Dosage & Pricing Insight • Number Of Targeted Alpha Therapy In Clinical Trials: > 20 Drugs • Targeted Alpha Therapy Clinical Trials Insight By Company, Country, Indication & Phase • Marketed Targeted Alpha Therapy Clinical Insight By Company, Country & Indication • Targeted Alpha Therapy Proprietary Technology Platform Insights By
Dark Truth Behind Targeted Violence
Intimidation and cyberbullying public bullying the (target)victims selected into committing the violent criminal acts if the victims mentality was broken. The perpetrators are small fraud groups organizing misinformation with false profiles for the public to participate with public bullying while the groups stalk the victim. San Diego California 2021-2024 plot failed federal agents on standby monitoring the targets failed at there duties of integrity while presidential elections push towards Nov 5 San
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are designed to recognize and bind two different antigens simultaneously, providing a more comprehensive attack on cancer cells and improving treatment outcomes. One of the most successful examples of BsAbs is blinatumomab, which targets CD19 on B-cells and CD3 on T-cells. Blinatumomab has shown remarkable efficacy in
Targeted Email Leads: Pioneering a New Era in Email Marketing with High-Quality, …
GREENSBORO, NC - 15 August 2024 - In the rapidly evolving digital landscape, one company is setting new standards in email marketing. Targeted Email Leads, a trailblazer in the provision of precision-targeted email lists, is offering meticulously cleaned and verified lists that cater to a wide range of applications, from B2B communications to consumer engagement and interest groups. What sets Targeted Email Leads apart is their rigorous verification process. Each
Tetravalent Antibody as Cancer Targeted Therapy
The advent of tetravalent antibodies marks a significant breakthrough in cancer targeted therapy, offering a sophisticated approach to tackling the complex and heterogeneous nature of tumors. These antibodies, engineered to bind to four distinct antigens or epitopes simultaneously, provide enhanced specificity and efficacy, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Cancer is a multifaceted disease characterized by diverse cell populations within a
Targeted Advertising Solutions Market - Rising Demand from the Providers of Targ …
The rising popularity of digital channels such as mobile and online for media and entertainment, and communications, coupled with their capability to identify and benefit from tracking customer behavior accurately, have created major interest and increasing investments by advertisers on targeted advertising. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47862 Organizations making an entry into the advertising value network need to effectively educate, engage, and create alertness to the advantages of targeted